Bivalent Booster Effectiveness Against New SARS-CoV-2 Variants Bivalent Booster Effectiveness Against New SARS-CoV-2 Variants
This study confirms that a bivalent mRNA booster dose provides additional protection against symptomatic XBB/XBB.1.5 infection for at least 3 months after vaccination.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 17, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news
S2 Episode 2: COVID-19 and HIV S2 Episode 2: COVID-19 and HIV
Drs Michael S. Saag and Monica Gandhi discuss COVID-19 and the impact this pandemic has had on patients diagnosed with HIV, including vaccines, boosters, and patients who are older or have chronic comorbid conditions.Medscape (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 11, 2023 Category: Infectious Diseases Tags: HIV/AIDS InDiscussion Source Type: news
Africa: No, People Vaccinated Against Covid-19 Don't Develop Aids - Claim Peddled By Known False-Information Website
[Africa Check] IN SHORT: In early 2023 a familiar anti-vaxx rumour started spreading on social media again, claiming that people vaccinated against Covid-19 were developing "Aids-like symptoms". But there's - still - no evidence for this. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 8, 2023 Category: African Health Source Type: news
Parliamentarians Tackle Youth Employment, SRHR in Post-COVID Asia and Pacific
Delegates at the Youth Empowerment: Education, Employment and Sexual and Reproductive Health and Rights forum held in Phnom Penh, Kingdom of Cambodia. Credit: APDABy Cecilia RussellJOHANNESBURG, Mar 8 2023 (IPS) With more than 600 million youth aged between 18 and 24 in the Asia and Pacific region, putting their issues front and center is crucial. Speakers at a recent forum, Youth Empowerment: Education, Employment and Sexual and Reproductive Health and Rights, held in Phnom Penh, Kingdom of Cambodia, agreed that policy development and implementation should be youth-centered.
Professor Keizo Takemi, MP (Japan) and Chair of...
Source: IPS Inter Press Service - Health - March 8, 2023 Category: International Medicine & Public Health Authors: Cecilia Russell Tags: Asia-Pacific COVID-19 Featured Headlines Innovation Labour Population TerraViva United Nations Youth Asian Forum of Parliamentarians on Population and Development (AFPPD) Asian Population and Development Association (APDA) Cambodia Source Type: news
Reduced Risk for Mpox Risk After Receipt of JYNNEOS Vaccine Reduced Risk for Mpox Risk After Receipt of JYNNEOS Vaccine
Evidence in this CDC report indicates that JYNNEOS vaccination provides significant protection against monkeypox after two doses.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 3, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news
Meningococcal Vaccine Shows Benefit in STI Prevention Meningococcal Vaccine Shows Benefit in STI Prevention
A new trial looks at the effect of doxycycline post-exposure prophylaxis and vaccination with meningococcal B vaccine on rates of sexually transmitted infections in men who have sex with men.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 22, 2023 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Case studies expose deadly risk of mpox in people with untreated HIV
In June 2022, a young man in his 30s severely sick with mpox, the viral disease formerly known as monkeypox, was admitted to the Salvador Zubirán National Institute of Health Sciences and Nutrition hospital in Mexico City. Tests showed the patient was also HIV-positive, which he had not known, and that his blood had few CD4 cells, critical immune cells that HIV attacks. The man’s immune system was so weak it could not keep mpox in check and painful lesions kept spreading across his body, eating away at, or necrotizing, the flesh, according to HIV researcher Brenda Crabtree Ramirez, who was on his care team. Then the vir...
Source: ScienceNOW - February 21, 2023 Category: Science Source Type: news
Mpox in Patient Immunized with ACAM2000 Smallpox Vaccine Mpox in Patient Immunized with ACAM2000 Smallpox Vaccine
A patient contracted mpox despite having previously received a smallpox vaccine. Why was infection not prevented in this case?Emerging Infectious Diseases (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 21, 2023 Category: Infectious Diseases Tags: Infectious Diseases Journal Article Source Type: news
Progress Toward Regional Measles Elimination 2000-2021 Progress Toward Regional Measles Elimination 2000-2021
This study found that worldwide vaccination rates for measles fell throughout the pandemic, dropping to the lowest since 2008.Morbidity & Mortality Weekly Report (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 15, 2023 Category: Infectious Diseases Tags: Public Health & Prevention Journal Article Source Type: news
Researchers Voice'Frustration' at Failed HIV Vaccine Trial Researchers Voice'Frustration' at Failed HIV Vaccine Trial
An interim analysis determined that the regimen was not effective in preventing infections, compared with placebo.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 13, 2023 Category: Allergy & Immunology Tags: HIV/AIDS News Source Type: news
Prognosis of Hepatitis E in Patients With Chronic Liver Disease Prognosis of Hepatitis E in Patients With Chronic Liver Disease
This analysis found a high prevalence of hepatitis E infection in hospitalized patients with chronic liver disease, suggesting that HEV vaccination is appropriate for patients with pre-existing CLD.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 13, 2023 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news
The 5 Biggest Changes in the 2023 Adult Vaccine Schedules The 5 Biggest Changes in the 2023 Adult Vaccine Schedules
AMA Liaison to ACIP Dr Sandra Fryhofer gives a quick tour of the 2023 vaccination schedules, highlighting what ' s new for this year.Medscape Internal Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 9, 2023 Category: Infectious Diseases Tags: Internal Medicine Commentary Source Type: news
So, Is the Pandemic Over Yet?
In his second State of the Union speech on Feb. 7, President Joe Biden made it clear that the Administration is moving into the next phase of the COVID-19 pandemic—one in which the threats of disease and death are considerably diminished, and therefore no longer require the resources and urgent allocation of funds that the previous two years have.
“While the virus is not gone…we have broken COVID’s grip on us,” Biden said. “And soon we’ll end the public health emergency.”
The President outlined his reasons for not renewing the COVID-19 national and public health emergencies w...
Source: TIME: Health - February 8, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Africa: HIV Vaccine Research Set to Change Focus in Wake of Mosaico Disappointment
[spotlight] Hopes for the Johnson & Johnson (J&J) Mosaico vaccine - the only HIV vaccine candidate in late-stage (Phase 3) clinical trials - were dashed with manufacturer Janssen Pharmaceuticals' recent announcement that the vaccine lacked efficacy in preventing HIV infection. In the wake of this announcement, top South African HIV clinicians are now setting their sights on different approaches to finding an HIV vaccine. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - January 30, 2023 Category: Infectious Diseases Source Type: news
Why inventing a vaccine for AIDS is tougher than for COVID
The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?(Image credit: Luke Dray/Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - January 26, 2023 Category: Consumer Health News Authors: Susan Brink Source Type: news
